Purdue Pharma L.P. v. Combs

506 S.W.3d 337, 2014 WL 794928, 2014 Ky. App. LEXIS 35
CourtCourt of Appeals of Kentucky
DecidedFebruary 28, 2014
DocketNo. 2013-CA-001941-OA
StatusPublished

This text of 506 S.W.3d 337 (Purdue Pharma L.P. v. Combs) is published on Counsel Stack Legal Research, covering Court of Appeals of Kentucky primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Purdue Pharma L.P. v. Combs, 506 S.W.3d 337, 2014 WL 794928, 2014 Ky. App. LEXIS 35 (Ky. Ct. App. 2014).

Opinion

OPINION AND ORDER DENYING PETITION FOR WRIT OF PROHIBITION

THOMPSON, Judge:

Petitioners, Purdue Pharma L.P., Individually, Purdue Pharma L.P., as succes[339]*339sor in interest to the Purdue Pharma Company, Purdue Pharma Inc., The Purdue Fredrick Company, Inc., d/b/a The Purdue Frederick Company, Purdue Pharmaceuticals, L.P., and The P.F. Laboratories, Inc. (Purdue) filed this petition for writ of prohibition seeking to prohibit the Pike Circuit Court from enforcing an order deeming certain requests for admissions served upon Purdue as admitted.

FACTUAL AND PROCEDURAL HISTORY

On October 4, 2007, the Commonwealth and co-plaintiff Pike County (on behalf of itself and a putative class of all Kentucky counties)1 filed this action in Pike Circuit Court against Purdue and Abbott Laboratories and Abbott Laboratories, Inc. (Abbott). The Commonwealth alleged Purdue and Abbott’s marketing and promotion of OxyContin tablets caused the Commonwealth damages including excessive spending on OxyContin through Medicaid and other Kentucky programs, health care services provided for the diagnosis and treatment of the adverse effects of OxyContin, and law enforcement, educational and social services to combat the abuse and diversion of OxyContin. At the same time, the Commonwealth served Purdue and Abbott with discovery pursuant to the Kentucky Rules , of Civil Procedure (CR), including requests for admissions pursuant to CR 36. So the significance of the trial court’s order deeming these requests admitted is readily understood, we reiterate those requests most damaging to Purdue’s defense as propounded:

ADMISSION NO. 5: That Defendant, acting alone or in concert with other persons or entities, including those named Defendants in this action,. misrepresented and/or concealed the true and actual addictive nature of OxyCon-tin, including but not limited to the risk of addiction, actual addiction and other adverse health consequences,
ADMISSION NO. 9: That Defendant promoted and marketed OxyContin to general practitioners and other physicians all of whom Defendant.knew had less training and experience in treating chronic pain.
ADMISSION NO. 12: That Defendant knew how to reduce or eliminate the addictive potential of OxyContin.
ADMISSION NO. 16: That Defendant and/or its agents did not warn the general public or practitioners of the true and actual addictive potential of OxyContin.
ADMISSION NO. 17: That the misrepresentations and/or omissions by Defendant caused OxyContin to be excessively over-prescribed.
ADMISSION NO. 18: That the misrepresentations and/or omissions by Defendant caused damage to the Plaintiff, Commonwealth of Kentucky, by causing it to expend excessive amounts of money on OxyContin through state-funded benefits.
ADMISSION NO. 20: That the misrepresentations and/or omissions by Defendant were in violation of state laws.

Purdue and Abbott .removed the case to federal court before the answer or discovery responses were due. On October 29, 2007, Purdue filed its answer to the complaint in federal court which included denials to allegations substantively identical to [340]*340those set forth in the requests for admissions.

For reasons not pertinent to the present issue, the case was not remanded to the Pike Circuit Court until February 8, 2018. On March 29, 2013, the Commonwealth filed a motion to have the requests for admissions served with its complaint almost six years earlier deemed admitted. Three days later, before Purdue received notice of this motion, the trial court entered an order granting the motion and deeming the requests admitted. Realizing the admissions would likely resolve the issue of their liability, Purdue and Abbott immediately filed motions to rescind the order and, on April 12, 2018, just eleven days after learning of the Commonwealth’s motion, Purdue filed its responses to the requests for admissions. On April 29, 2013, Purdue filed its motion to withdraw or amend any deemed admissions pursuant to CR 36.02. Abbott filed a similar motion. Following a hearing and briefing, without making specific findings of fact or conclusions of law, and for reasons not otherwise stated, the trial court granted Abbott’s motion but denied Purdue’s motion. Purdue filed this petition for a writ of prohibition.

STANDARD TO DETERMINE WHETHER A WRIT IS PROPER

Our Supreme Court has looked upon writs of prohibition and mandamus with disfavor. Kentucky courts “have always been cautious and conservative both in entertaining petitions for and in granting such relief.” Bender v. Eaton, 343 S.W.2d 799, 800 (Ky.1961). The reason for the reluctance to grant a writ is founded on the very nature of the judicial process.

This careful approach is necessary to prevent short-circuiting normal appeal procedure and to limit so far as possible interference with the proper and efficient operation of our circuit and other courts. If this avenue of relief were open to all Who considered themselves aggrieved by an interlocutory court order, we would face an impossible burden of nonappellate matters.

Id. Our Supreme Court has sternly cautioned: “[T]he specter of injustice always hovers over writ proceedings, which explains why courts of this Commonwealth are—and should be—loath to grant the extraordinary writs unless absolutely necessary.” Cox v. Braden, 266 S.W.3d 792, 795 (Ky.2008).

Consequently, strict requirements have been set forth to establish entitlement to a writ. “[Ojnly after determining that the prerequisites exist will the court decide whether an error occurred for which a writ should issue.” Hoskins v. Maricle, 150 S.W.3d 1, 18 (Ky.2004). Petitioners must “satisfy one of two tests to determine whether the remedy of a writ is even available.” Edwards v. Hickman, 237 S.W.3d 183, 188 (Ky.2007).

A writ of prohibition may be granted upon a showing that (1) the lower court is proceeding or is about to proceed outside of its jurisdiction and there is no remedy through an application to an intermediate court; or (2) that the lower court is acting or is about to act erroneously, although within its jurisdiction, and there exists no adequate remedy by appeal or otherwise and great injustice and irreparable injury will result if the petition is not granted.

Hoskins, 150 S.W.3d at 10. “The second class of writs includes a subset for ‘certain special cases’ where ‘a substantial miscarriage of justice will result if the lower court is proceeding erroneously, and correction of the error is necessary and appropriate in the interest of orderly judicial administration.’ ” Edwards, 237 S.W.3d at [341]*341188 (quoting Bender, 343 S.W.2d at 801). The exception is limited and applies only “where the action for which the writ is sought would blatantly violate the law, for example, by breaching a tightly guarded privilege or by contradicting the clear requirements of a civil rule.” Indep.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Davis v. Traub
565 P.2d 1015 (New Mexico Supreme Court, 1977)
Independent Order of Foresters v. Chauvin
175 S.W.3d 610 (Kentucky Supreme Court, 2005)
Hinkle v. Black
262 S.E.2d 744 (West Virginia Supreme Court, 1979)
Edwards v. Hickman
237 S.W.3d 183 (Kentucky Supreme Court, 2007)
Hoskins v. Maricle
150 S.W.3d 1 (Kentucky Supreme Court, 2004)
Bender v. Eaton
343 S.W.2d 799 (Court of Appeals of Kentucky (pre-1976), 1961)
National Gypsum Co. v. Corns
736 S.W.2d 325 (Kentucky Supreme Court, 1987)
Cox v. Braden
266 S.W.3d 792 (Kentucky Supreme Court, 2008)
State Ex Rel. Golden v. Crawford
165 S.W.3d 147 (Supreme Court of Missouri, 2005)
Thermorama, Inc. v. Shiller
135 N.W.2d 43 (Supreme Court of Minnesota, 1965)
Mahoney v. McDonald-Burkman
320 S.W.3d 75 (Kentucky Supreme Court, 2010)
Estate of Cline v. Weddle
250 S.W.3d 330 (Kentucky Supreme Court, 2008)
Berrier v. Bizer
57 S.W.3d 271 (Kentucky Supreme Court, 2001)
Walker v. Packer
827 S.W.2d 833 (Texas Supreme Court, 1992)
Ison v. Bradley
333 S.W.2d 784 (Court of Appeals of Kentucky (pre-1976), 1960)
State Farm Insurance Co. v. Edwards
339 S.W.3d 456 (Kentucky Supreme Court, 2011)
Commonwealth, Energy & Environment Cabinet v. Shepherd
366 S.W.3d 1 (Kentucky Supreme Court, 2012)
St. Clair v. Castlen
381 S.W.3d 306 (Kentucky Supreme Court, 2012)
Premiertox 2.0 v. Miniard
407 S.W.3d 542 (Kentucky Supreme Court, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
506 S.W.3d 337, 2014 WL 794928, 2014 Ky. App. LEXIS 35, Counsel Stack Legal Research, https://law.counselstack.com/opinion/purdue-pharma-lp-v-combs-kyctapp-2014.